|
KMID : 0359720190370020171
|
|
Journal of the Korean Neurological Association
2019 Volume.37 No. 2 p.171 ~ p.173
|
|
|
Improved Bulbar Function in Amyotrophic Lateral Sclerosis after Nuedexta (Dextromethorphan and Quinidine) Treatment
|
|
Cho Hee-Jin
Park Jin-Mo
Park Jin-Sung
|
|
|
Abstract
|
|
|
|
Nuedexta (dextromethorphan and quinidine) is an Food and Drug Administration approved medication for pseudobulbar affect. Interestingly, this drug was recently reported to improve speech, swallowing, and the ability to handle oral secretions along with emotional lability in amyotrophic lateral sclerosis (ALS) patients with bulbar symptoms. We report a Korean ALS patient whose bulbar function improved after administering Nuedexta for 6 months, extending therapeutic choice of approach in treating ALS patients.
|
|
|
KEYWORD
|
|
|
Dextromethorphan, Quinidine, Amyotrophic lateral sclerosis
|
|
|
FullTexts / Linksout information
|
|
|
|
|
Listed journal information
|
|
  
|